Address
Building 5
Weybridge, KT13 0NY
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 1932 822000
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
24561
First IPO Date
July 18, 2022
| Name | Title | Pay | Year Born |
| Brian James McNamara | Chief Executive Officer & Executive Director | 2.86M | 1966 |
| Dawn Amanda Allen | Chief Financial Officer & Director | 1.54M | 1968 |
| Adrian Charles Morris | General Counsel | 0 | 1967 |
| Tamara Rogers | Chief Marketing Officer | 0 | 1968 |
| Bjorn Timelin | Head of Strategy | 0 | N/A |
| Filippo Lanzi | President of EMEA & LatAm | 0 | N/A |
| Line De Decker | Chief Human Resources Officer | 0 | 1974 |
| Keith Choy | President of Asia Pacific | 0 | 1969 |
| Claire Dickson | Chief Digital & Technology Officer | 0 | N/A |
| Joanne Russell | Head of Investor Relations | 0 | N/A |
Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.